UPCC 12523: Real-world efficacy and safety, patterns of resistance and clinical progression among patients with Non-Small Cell Lung Cancer harboring EGFR exon 20 insertion mutations: An ATOMIC Analysis
Enrolling By Invitation
99 years and younger
All
Phase
N/A
1 Location
Brief description of study
This study is a retrospective and prospective medical record review of patients with NSCLC harboring EGFR ex20ins mutations treated at cancer centers participating in ATOMIC.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Updated on
01 Aug 2024.
Study ID: 854158
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
